for Performance Horses
2 million performance horses will suffer a tendon/ligamentinjury
Currentsolutions take 9-12 months and often are ineffective, necessitating euthanasia
Athletes, both equine and human, are expensive;
$6B market opportunity
CellDrop is commercializing a first of its kind encapsulated, allogeneic stem cell therapy for faster and more durable healing of superficial digital flexor tendon and suspensory ligament injuries in performance horses.
Implementation in the veterinary market serves as a stepping stone to human translation, where preliminary evidence shows great promise for reversing debilitating orthopedic conditions like Osteoarthritis.